News about "CDMO partnership"

Gland Pharma Announces Strategic CDMO Partnership with Global Pharmaceutical Company

Gland Pharma Announces Strategic CDMO Partnership with Global Pharmaceutical Company

Gland Pharma has partnered with a global pharmaceutical company to provide end-to-end Contract Development and Manufacturing Organisation (CDMO) services across commercial and pipeline products throughout their lifecycle.

CDMO Partnership | 11/08/2026 | By News Bureau |  119

Shilpa Biologicals Launches PartnerPower Platform for Real-time Visibility on Process Development and GMP Manufacturing

Shilpa Biologicals Launches PartnerPower Platform for Real-time Visibility on Process Development and GMP Manufacturing

Shilpa Biologicals has launched PartnerPower, a proprietary platform offering real-time visibility into process development and Good Manufacturing Practice (GMP) manufacturing, setting a new benchmark for transparency in CDMO operations.

CDMO Partnership | 24/06/2026 | By News Bureau |  142

Shilpa Medicare Signs Long-Term Manufacturing and Development Pact with NXI Therapeutics AG

Shilpa Medicare Signs Long-Term Manufacturing and Development Pact with NXI Therapeutics AG

Shilpa Medicare and NXI Therapeutics AG have entered into a long-term agreement to support development and commercial manufacturing of immunomodulatory therapies, expanding Shilpa’s global CDMO footprint in high-growth biologics and specialty therapeutics.

CDMO Partnership | 14/05/2026 | By News Bureau |  175

Neuland Laboratories Partners with LIR Life Sciences Corp to Advance Transdermal GLP-1 Obesity Therapy

Neuland Laboratories Partners with LIR Life Sciences Corp to Advance Transdermal GLP-1 Obesity Therapy

Neuland Laboratories partnership with LIR Life Sciences Corp will focus on developing and manufacturing cell-penetrating peptides to support LIR Life’s patch-based GLP-1/GIP obesity treatment platform.

CDMO Partnership | 07/05/2026 | By News Bureau |  246

Novelty Nobility Partners with AGC Biologics to Advance Bispecific Drug Candidate

Novelty Nobility Partners with AGC Biologics to Advance Bispecific Drug Candidate

Novelty Nobility partners with AGC Biologics to advance a bispecific Antibody Drug Candidate (ADC) into GMP manufacturing, showcasing Japan’s bioprocessing expertise and AGC Biologics’ global development network.

CDMO Partnership | 04/05/2026 | By News Bureau |  148


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members